These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15013335)

  • 1. Clinical course of a renal transplant recipient with malignant fibrous histiocytoma: a case report.
    Ghods AJ; Nasrollahzadeh D; Asgari M; Fazel I
    Transplant Proc; 2004; 36(1):166-7. PubMed ID: 15013335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder cancer in patients after organ transplantation.
    Wallerand H; Ravaud A; Ferrière JM
    Curr Opin Urol; 2010 Sep; 20(5):432-6. PubMed ID: 20644482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
    Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
    Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis infection following renal transplantation in Taiwan.
    Chen CH; Lian JD; Cheng CH; Wu MJ; Lee WC; Shu KH
    Transpl Infect Dis; 2006 Sep; 8(3):148-56. PubMed ID: 16913973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies.
    Sommerer C; Konstandin M; Dengler T; Schmidt J; Meuer S; Zeier M; Giese T
    Transplantation; 2006 Nov; 82(10):1280-5. PubMed ID: 17130775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation.
    Butani L
    Pediatr Transplant; 2005 Dec; 9(6):746-53. PubMed ID: 16269046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus.
    Ersoy A; Ersoy C; Tekce H; Yavascaoglu I; Dilek K
    Transplant Proc; 2004 Jun; 36(5):1407-10. PubMed ID: 15251345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant fibrous histiocytoma of the meninges. A case report].
    Santos-Ditto R; Santos-Franco JA; Pinos-Gavilanes M
    Rev Neurol; 2004 Jun 16-30; 38(12):1198-200. PubMed ID: 15229835
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical fibroxanthoma of the external ear in a cardiac transplant recipient: case report and the causal role of the immunosuppressive therapy.
    Ferri E; Iaderosa GA; Armato E
    Auris Nasus Larynx; 2008 Jun; 35(2):260-3. PubMed ID: 17804184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi sarcoma in solid organ transplant recipients: a single center report.
    Boeckle E; Boesmueller C; Wiesmayr S; Mark W; Rieger M; Tabarelli D; Graziadei I; Hoefer D; Antretter H; Stelzmueller I; Krugmann J; Zangerle R; Huemer H; Poelzl G; Margreiter R; Bonatti H
    Transplant Proc; 2005 May; 37(4):1905-9. PubMed ID: 15919500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure.
    Carmellini M; Collini A; Ruggieri G; Garosi G; Bernini M
    Transplant Proc; 2008; 40(6):1858-61. PubMed ID: 18675070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous malignant fibrous histiocytoma of the scalp in a renal transplant recipient.
    Stein A; Hackert I; Sebastian G; Meurer M
    Br J Dermatol; 2006 Jan; 154(1):183-5. PubMed ID: 16403118
    [No Abstract]   [Full Text] [Related]  

  • 14. Case of adult mumps infection after renal transplantation.
    Park SB; Jin KB; Hwang EA; Han SY; Kim HC; Kim HT; Cho WH; Kwak JH; Ahn KS
    Transplant Proc; 2008 Sep; 40(7):2442-3. PubMed ID: 18790262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
    Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
    Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-dihydroxyvitamin D(3) therapy is protective for renal function and prevents hyperparathyroidism in renal allograft recipients.
    Uyar M; Sezer S; Arat Z; Elsurer R; Ozdemir FN; Haberal M
    Transplant Proc; 2006 Sep; 38(7):2069-73. PubMed ID: 16980002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum C-reactive protein surge in renal transplant recipients: link with allograft survival.
    Ozdemir NF; Elsurer R; Ibis A; Arat Z; Haberal M
    Transplant Proc; 2007 May; 39(4):934-7. PubMed ID: 17524855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple atypical fibroxanthomas in a cardiac transplant recipient.
    Kovach BT; Sams HH; Stasko T
    Dermatol Surg; 2005 Apr; 31(4):467-70. PubMed ID: 15871326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of subcutaneous phaeohyphomycosis and prospective follow-up of 17 kidney transplant recipients.
    Ogawa MM; Galante NZ; Godoy P; Fischman-Gompertz O; Martelli F; Colombo AL; Tomimori J; Medina-Pestana JO
    J Am Acad Dermatol; 2009 Dec; 61(6):977-85. PubMed ID: 19815309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
    Chang HR; Lin CC; Lian JD
    Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.